Hypothetical model for the pathological-clinical continuum of Alzheimer’s disease

Professor Dr. Per Borghammer unpacks the brain-first vs body-first model of Parkinson’s disease, exploring distinct pathways of progression from the gut or nose and their potential to drive personalized medicine and innovative treatments.

Discover how human models of migraine have identified key molecular triggers like CGRP and PACAP, revolutionizing treatment options and offering hope for patients unresponsive to current therapies.